Aclaris Therapeutics Reports Third Quarter 2017 Financial Results
Nov 07, 2017 12:02 pm UTC| Business
Management to Host Conference Call at 8:00 AM ET today MALVERN, Pa., Nov. 07, 2017 -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a dermatologist-led biopharmaceutical company focused on identifying, developing, and...
Vericel Reports Third-Quarter 2017 Financial Results
Nov 07, 2017 12:02 pm UTC| Business
Record Third Quarter Revenue of $14.3 Million Represents a 30% Increase Over Third Quarter 2016 Results Driven by Continued Momentum of MACI Uptake and Expanded Epicel Usage Conference Call Today at 8:00am Eastern...
Nov 07, 2017 12:01 pm UTC| Business
ALAMEDA, Calif., Nov. 07, 2017 -- Jitterbit, the API transformation company, today announced it has raised $25 million in a Series C funding round led by KKR. Jitterbit plans to use the additional capital to increase...
Algold Extends Tijirit’s High-Grade Gold Mineralization at Depth
Nov 07, 2017 12:01 pm UTC| Business
MONTREAL, Nov. 07, 2017 -- ALGOLD RESOURCES LTD. (TSXV: ALG – “Algold” or the “Corporation”) today announced additional assay results from diamond (“DDH”) and reverse-circulation (“RC”) drilling carried out on its...
Nov 07, 2017 12:01 pm UTC| Business
NEW YORK, Nov. 07, 2017 -- JPMorgan Chase Co., UnitedHealth Group, Enterprise Products Partners, Schlumberger, and T-Mobile — swept their respective sectors, ranking first across the CEO, CFO, and investor relations...
Antares Pharma Reports Third Quarter 2017 Operating and Financial Results
Nov 07, 2017 12:01 pm UTC| Business
EWING, N.J., Nov. 07, 2017 -- Antares Pharma, Inc. (NASDAQ:ATRS) today reported operating and financial results for the third quarter ended September 30, 2017. The Company reported record revenue of $15.1 million and a...
Nov 07, 2017 12:01 pm UTC| Business
Geneva, Switzerland and Boston, MA - November 7, 2017 - ObsEva SA (NASDAQ: OBSV), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions...
UK Inflation Stabilizes: November CPI at 2.6%, Signaling Economic Recovery
FDA Approval of Opdivo Injection Sparks Hope for Cancer Patients with Revolutionary Treatment Update